TrialsNest
Sign Up
Research Sites

Single IRB readiness checklist for multisite clinical trials

A readiness checklist for research sites preparing single IRB workflows, reliance documentation, consent control, training, and local approvals.

Research SitesUpdated 2026-06-155 min read

Single IRB workflows can reduce duplicated review, but research sites still need clear local responsibilities, reliance documentation, consent version control, and communication paths.

Published Updated By TrialsNest editorial
Editorial review

How this resource is reviewed

Reviewed by TrialsNest editorial review on . These guides are written for operational education and updated when workflow, buyer, or trust boundaries change.

Editorial lens

How to use the tool without making it busywork

A useful single IRB readiness checklist should produce an owner, blocker, date, decision, or next action. If it only creates another document, the workflow still needs a sharper operating habit.

Completing the checklist away from the queue

The best review happens beside real work, where missing records, stale leads, and owner gaps are visible.

Leaving the result out of the next meeting

A checklist should feed the next coordinator, site, sponsor, or operations conversation.

Decision checklist

Before using it

Gather the current owner, status, blocker, source, and last meaningful movement.

While using it

Mark which answers need action instead of treating every item as equal.

After using it

Put the owner, due date, or reporting note back into the workflow.

What to keep in view

Single IRB readiness is operational, not only regulatory.
Sites should separate central IRB review from local institutional approvals and ancillary steps.
Coordinator training should cover approved documents, reporting paths, consent versions, and local context requirements.

Operator questions

What item on this checklist would change today's queue?
Which answer needs a named owner or due date?
What should be reviewed again next week?

How teams usually use it

Compare it with the real queue

Read it next to the way your team already works. The gaps usually show up around ownership, missing records, follow-up timing, or sponsor-update prep.

Mark the handoffs

For each section, ask where the work changes hands. If the handoff depends on memory, a spreadsheet tab, or a buried message, that is probably worth fixing.

Keep the boundary clear

When the topic touches matching or prescreening, keep the language careful. Early fit is not enrollment, and final study decisions stay with authorized study teams.

Practical scenario

A practical use case

Use the checklist during a live recruitment review, then convert the answer into a queue update, sponsor note, source-quality decision, or follow-up task.

Before: the team agrees the issue matters but leaves without a visible owner.
After: the checklist creates a specific owner, blocker reason, and next review point.

Focused next reads for this topic

These links keep the page inside the same practical topic path instead of sending readers through broad navigation.

See it in TrialsNest

Turn this guide into a working recruitment workflow.

Walk through how patient intake, prescreening, records readiness, scheduling, and reporting connect in the product.

Single IRB readiness is operational

For many multisite studies, a single Institutional Review Board model can reduce duplicated review and create a more consistent oversight process.

NIH policy generally expects a single IRB for domestic sites in NIH-funded multisite research involving non-exempt human subjects research. For sites, the practical question is not only who the IRB is. It is whether the site is operationally ready to work under that model.

Confirm roles early

Know which IRB is reviewing the study, which institutions are relying on that review, who owns local context updates, and who handles communication between the site, sponsor, coordinating center, and IRB.

The readiness checklist should name the local owner for every dependency. Reliance agreements, local context language, ancillary reviews, training confirmations, and site activation notes should not live only in email threads.

Sites should also identify which local steps remain required. Even under a single IRB, a site may still need institutional sign-off, conflict-of-interest review, ancillary committee review, training confirmation, or other local approvals.

Use a case-study lens

A multisite study launches with central IRB approval, but one site delays activation because local ancillary review was not started. The issue is not the single IRB model itself. The issue is that local steps were invisible until the launch timeline was already compressed.

A better site activation checklist separates central IRB review from local institutional steps and assigns an owner to each dependency.

Turn readiness into activation checks

Before patient outreach begins, the site should confirm active consent documents, approved recruitment language, local contacts, escalation paths, staff training, and any sponsor or coordinating-center instructions that affect patient-facing workflow.

That checklist should be reviewed again when a document version changes. A single IRB workflow can still create local execution risk if coordinators do not know which materials are current or who approves the next change.

Where TrialsNest fits

TrialsNest is not an IRB system, but recruitment teams still benefit when study activation dependencies, site readiness notes, document status, coordinator tasks, and patient-facing workflow steps are visible together.

The goal is to prevent enrollment operations from assuming a site is ready before the required review, documentation, training, and local activation steps are complete and current.

Sources used for this checklist

NIH Single IRB Policy for Multi-Site Research explains the policy context for many domestic multisite research studies: https://grants.nih.gov/policy-and-compliance/policy-topics/single-irb-policy-multi-site-research

HHS OHRP IRBs and Assurances guidance explains registration and assurance context for human-subjects research oversight: https://www.hhs.gov/ohrp/register-irbs-and-obtain-fwas/index.html

Site next step

Want this workflow organized in one place?

See how TrialsNest connects patient intake, prescreening, records readiness, coordinator follow-up, scheduling, and reporting for research sites.

Related TrialsNest workflows

These resource pages connect back to the product areas buyers usually ask about: public study search, site recruitment workflow, sponsor visibility, and the privacy-aware operating model.

Trust Center

Topics covered

single IRB readiness checklistmultisite trial IRBsIRB readiness checklist

Common questions

What should teams know about single IRB readiness checklist?

Single IRB workflows can reduce duplicated review, but research sites still need clear local responsibilities, reliance documentation, consent version control, and communication paths. The practical value is in connecting the concept to ownership, follow-up, records readiness, scheduling, reporting, and clear next actions.

Who is this resource written for?

This resource is written for research sites sorting through practical questions around single IRB readiness checklist and the workflow decisions that usually come with it.

Does this guide replace study-team review or medical advice?

No. TrialsNest resources are educational and operational. They do not provide medical advice, diagnosis, treatment, emergency care, or final clinical trial eligibility decisions.

How would a team use this workflow guidance in practice?

Use it to compare the current workflow with what actually happens day to day: where leads wait, where records get lost, where follow-up slows down, and what needs a clearer owner. The best next step is to turn the article takeaways into a short review checklist for single IRB readiness checklist.

Trust and proof points

Study-team decisions stay with authorized teams

TrialsNest can organize intake, prescreening, and workflow context, but it does not make final eligibility, enrollment, treatment, or medical decisions.

Reporting focuses on operational movement

Sponsor-ready updates should show source quality, movement, blockers, and next actions without becoming a broad patient-detail workspace.

Public pages stay educational

These resources explain clinical recruiting workflows and buying decisions. Sensitive study details belong in the appropriate secure workflow.

!
Heads up
Medical and eligibility decisions stay with the study team
TrialsNest does not provide medical advice, diagnosis, treatment, emergency care, or final study eligibility decisions. Authorized study teams review each protocol and applicant.

Continue exploring

Helpful next reads

Follow-up reading chosen from the same topic cluster and audience context as this guide.

Cookie preferences
Learn more about cookies

Essential cookies keep the site working. Optional cookies help improve traffic and regional insights.